GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » Days Sales Outstanding

China Health Industries Holdings (China Health Industries Holdings) Days Sales Outstanding : 0.00 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings Days Sales Outstanding?

China Health Industries Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was $0.00 Mil. China Health Industries Holdings's Revenue for the three months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for China Health Industries Holdings's Days Sales Outstanding or its related term are showing as below:

CHHE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 28.08   Med: 67.75   Max: 196.16
Current: 28.08

During the past 13 years, China Health Industries Holdings's highest Days Sales Outstanding was 196.16. The lowest was 28.08. And the median was 67.75.

CHHE's Days Sales Outstanding is ranked better than
88.81% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs CHHE: 28.08

China Health Industries Holdings's Days Sales Outstanding declined from Dec. 2022 (24.89) to Dec. 2023 (0.00).


China Health Industries Holdings Days Sales Outstanding Historical Data

The historical data trend for China Health Industries Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings Days Sales Outstanding Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.75 121.64 196.16 - 32.59

China Health Industries Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.89 39.11 14.16 - -

Competitive Comparison of China Health Industries Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's Days Sales Outstanding falls into.



China Health Industries Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

China Health Industries Holdings's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (0.01 + 0) / 1 ) / 0.112*365
=0.01 / 0.112*365
=32.59

China Health Industries Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Industries Holdings  (OTCPK:CHHE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


China Health Industries Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Industries Holdings (China Health Industries Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
Sun Xin director, 10 percent owner, officer: CEO, CFO and Treasurer NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing director, officer: Secretary 2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson director 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster director 402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn director, officer: COO 422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee 10 percent owner 3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems 10 percent owner, officer: President, CEO, CFO and, other: Secretary 1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines